Quipt Home Medical Second Quarter 2025 Earnings: Misses Expectations

Simply Wall St

May 14, 2025

Quipt Home Medical (TSE:QIPT) Second Quarter 2025 Results

Key Financial Results

Revenue: US$57.4m (down 6.3% from 2Q 2024).
Net loss: US$3.04m (loss widened by 123% from 2Q 2024).
US$0.07 loss per share (further deteriorated from US$0.032 loss in 2Q 2024).

Our free stock report includes 3 warning signs investors should be aware of before investing in Quipt Home Medical. Read for free now.

earnings-and-revenue-growth — TSX:QIPT Earnings and Revenue Growth May 14th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Quipt Home Medical Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 9.0%. Earnings per share (EPS) also missed analyst estimates.

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 11% growth forecast for the Healthcare industry in Canada.

Performance of the Canadian Healthcare industry.

The company's shares are down 21% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with Quipt Home Medical (at least 1 which shouldn't be ignored), and understanding them should be part of your investment process.

Valuation is complex, but we're here to simplify it.

Discover if Quipt Home Medical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.